Walleye Trading
TAK icon

Walleye Trading’s Takeda Pharmaceutical TAK Stock Holding History

Walleye Trading’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$750K Sell
40,500
-24,600
-38% -$432K ﹤0.01% 2322
2025
Q4 		$1.01M Buy
65,100
+40,200
+161% +$575K ﹤0.01% 2370
2025
Q3 		$365K Buy
+24,900
New +$370K ﹤0.01% 2966
2025
Q2 		– Sell
-20,000
Closed -$297K – 4694
2025
Q1 		$297K Buy
20,000
+15,000
+300% +$210K ﹤0.01% 2840
2024
Q4 		$66.2K Sell
5,000
-10,100
-67% -$139K ﹤0.01% 3710
2024
Q3 		$215K Buy
+15,100
New +$214K ﹤0.01% 3018
2024
Q2 		– Sell
-25,400
Closed -$353K – 4891
2024
Q1 		$353K Sell
25,400
-21,900
-46% -$318K ﹤0.01% 3057
2023
Q4 		$675K Sell
47,300
-112,800
-70% -$1.6M ﹤0.01% 2810
2023
Q3 		$2.48M Sell
160,100
-122,200
-43% -$1.89M 0.01% 1627
2023
Q2 		$4.43M Buy
282,300
+38,500
+16% +$631K 0.01% 1038
2023
Q1 		$4.02M Buy
243,800
+63,900
+36% +$1.02M 0.01% 1198
2022
Q4 		$2.81M Sell
179,900
-9,400
-5% -$131K 0.01% 1454
2022
Q3 		$2.46M Buy
189,300
+179,300
+1,793% +$2.49M 0.01% 1536
2022
Q2 		$140K Sell
10,000
-33,500
-77% -$478K ﹤0.01% 3954
2022
Q1 		$623K Sell
43,500
-7,400
-15% -$109K ﹤0.01% 2688
2021
Q4 		$694K Sell
50,900
-21,700
-30% -$304K ﹤0.01% 2610
2021
Q3 		$1.19M Buy
72,600
+64,800
+831% +$1.09M ﹤0.01% 2033
2021
Q2 		$131K Hold
7,800
– – ﹤0.01% 4246
2021
Q1 		$142K Buy
7,800
+100
+1% +$1.8K ﹤0.01% 3897
2020
Q4 		$140K Buy
+7,700
New +$135K ﹤0.01% 3747
2020
Q1 		– Sell
-484,145
Closed -$9.55M – 4551
2019
Q4 		$9.55M Hold
484,145
– – 0.07% 298
2019
Q3 		$8.33M Sell
484,145
-574,023
-54% -$9.93M 0.07% 259
2019
Q2 		$18.7M Sell
1,058,168
-125,594
-11% -$2.29M 0.16% 88
2019
Q1 		$24.1M Buy
+1,183,762
New +$23.8M 0.19% 66

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Walleye Trading's TAK Position: Q1 2026 in Review

Walleye Trading sold out of Takeda Pharmaceutical (TAK) in Q1 2026, closing a stake of 27,062 shares — an estimated $475K sold.

Walleye Trading first reported a position in TAK in Q1 2019 and held it in 10 quarters. The position peaked at $17.5M in Q1 2019. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Walleye Trading reported no remaining Takeda Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 27,062 Takeda Pharmaceutical shares in Q1 2026, an estimated $475K.
  • Walleye Trading first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 10 quarters.
  • Walleye Trading's Takeda Pharmaceutical position peaked at $17.5M in Q1 2019.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.